Definitive Healthcare CEO awarded 1.7M RSUs

Coop Kevin reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Coop Kevin reported acquisition or exercise transactions in this Form 4 filing.

Definitive Healthcare Corp. reported that Chief Executive Officer Kevin Coop received an equity award linked to 1,735,437 shares of Class A Common Stock in the form of restricted stock units. These RSUs vest 25% on March 1, 2027, then 6.25% every three months over the next three years, contingent on his continued service. Following this grant, Coop is reported as beneficially owning 5,291,989 shares of Class A Common Stock.

Insider Trade Summary

Grant/Award: 1,735,437 shares

Grant/Award 1 txn

Insider Coop Kevin

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	1,735,437	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 5,291,989 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, with 25% of the RSUs vesting on March 1, 2027, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Definitive Healthcare (DH) CEO Kevin Coop receive in this Form 4?

Kevin Coop received a grant of restricted stock units representing 1,735,437 shares of Class A Common Stock. These RSUs are a form of equity compensation that entitle him to receive shares as they vest over time, subject to continued service.

How do Kevin Coop’s new RSUs at Definitive Healthcare (DH) vest?

The RSUs vest 25% on March 1, 2027, then 6.25% every three months for three additional years. Vesting occurs only if Kevin Coop continues his service with Definitive Healthcare through each scheduled vesting date, aligning his incentives with longer-term company performance.

Does this Form 4 for Definitive Healthcare (DH) show a stock purchase or sale?

No open-market purchase or sale is reported. The Form 4 shows an equity award coded as a grant or other acquisition, with a price per share of $0.00, reflecting compensation rather than a traditional buy or sell transaction in the market.

How many Definitive Healthcare (DH) shares does Kevin Coop hold after this grant?

After this equity award, Kevin Coop is reported as beneficially owning 5,291,989 shares of Class A Common Stock. This total includes the newly granted restricted stock units, which will convert into shares only as they vest over the defined schedule.

What type of security is involved in Kevin Coop’s Definitive Healthcare (DH) Form 4?

The filing involves Class A Common Stock delivered through restricted stock units. Each RSU represents a contingent right to receive one share of Class A Common Stock, par value $0.001, upon satisfying the specified vesting and continued service conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:53 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coop Kevin

(Last) (First) (Middle)

C/O DEFINITIVE HEALTHCARE CORP.

492 OLD CONNECTICUT PATH, SUITE 401

(Street)

FRAMINGHAM MA 01701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Definitive Healthcare Corp. [ DH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/24/2026		A		1,735,437(1)	A	$0	5,291,989	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, with 25% of the RSUs vesting on March 1, 2027, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date.

	/s/ Jonathan Paris, Attorney-in-Fact	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.